Your browser doesn't support javascript.
loading
Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer.
Twelves, Chris; Awada, Ahmad; Cortes, Javier; Yelle, Louise; Velikova, Galina; Olivo, Martin S; Song, James; Dutcus, Corina E; Kaufman, Peter A.
Afiliación
  • Twelves C; Section of Clinical Cancer Research, Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK.
  • Awada A; Medical Oncology Clinic, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
  • Cortes J; Vall D'Hebron University Institute of Oncology, Barcelona, Spain.; Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain.
  • Yelle L; Department of Medicine, University of Montreal, Montreal, QC, Canada.
  • Velikova G; Department of Oncology, Leeds Institute of Cancer and Pathology, and St James's Institute of Oncology, University of Leeds, Leeds, UK.
  • Olivo MS; Oncology PCU, Department of Clinical Development, Eisai Inc., Woodcliff Lake, NJ, USA.
  • Song J; Formerly of Department of Medical Affairs, Eisai Inc., Woodcliff Lake, NJ, USA.
  • Dutcus CE; Department of Clinical Development, Oncology, Eisai Inc., Woodcliff Lake, NJ, USA.
  • Kaufman PA; Section of Hematology/Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Breast Cancer (Auckl) ; 10: 77-84, 2016.
Article en En | MEDLINE | ID: mdl-27398025

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Breast Cancer (Auckl) Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Breast Cancer (Auckl) Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido